Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 7.85225 | 93 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 7.95259 | 93 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 8.08384 | 94 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 9.1103 | 96 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 8.40181 | 95 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 8.04536 | 94 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 7.94638 | 94 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 8.34998 | 95 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 8.26462 | 95 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 8.3381 | 95 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 7.64357 | 92 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 8.08665 | 94 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 7.89982 | 93 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 7.89787 | 93 |